Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:QCOM News 31 December 2025 - 12 January 2026

AMD stock jumps as Bernstein stays cautious on chipmaker and Wall Street frets Fed fight

AMD stock jumps as Bernstein stays cautious on chipmaker and Wall Street frets Fed fight

AMD shares rose 2.6% to $208.44 by 10:31 a.m. EST Monday, outperforming a slightly lower Nasdaq 100. Analyst Stacy Rasgon kept AMD at “market perform,” citing Nvidia’s growing lead in AI chips. Nvidia was flat, Broadcom gained 1.9%, and Intel fell 1.1%. AMD reports quarterly results Feb. 3.
12 January 2026
········
Qualcomm stock slides after Mizuho downgrade cuts target to $175, puts handset worries back in play

Qualcomm stock slides after Mizuho downgrade cuts target to $175, puts handset worries back in play

Qualcomm shares fell 2.25% to $177.78 after Mizuho downgraded the stock and cut its price target to $175, citing weak handset demand and Apple losing modem share. Volkswagen’s new supply deal with Qualcomm for its 2027 software platform highlighted the company’s automotive push. Qualcomm closed nearly 14% below its 52-week high. Investors await its Feb. 4 earnings call for guidance on handset and auto growth.
10 January 2026
··
Why Qualcomm stock moved: Volkswagen’s 2027 chip plan and Samsung 2nm talks

Why Qualcomm stock moved: Volkswagen’s 2027 chip plan and Samsung 2nm talks

Qualcomm shares rose 0.9% to $181.87 Thursday after Volkswagen named it main chip supplier for a new software platform launching in 2027. The stock traded between $176.51 and $184.29. Qualcomm is also in talks with Samsung to manufacture chips using a two-nanometre process. Investors await Friday’s U.S. jobs report and Qualcomm’s Feb. 4 earnings.
9 January 2026
·····
Qualcomm stock slips after report flags Samsung 2nm chip talks; earnings next

Qualcomm stock slips after report flags Samsung 2nm chip talks; earnings next

Qualcomm shares fell 2.6% to $177.79 Wednesday afternoon after CEO Cristiano Amon confirmed talks with Samsung on 2nm chip manufacturing. The drop outpaced the broader chip sector, with Taiwan Semiconductor and AMD also down, while Nvidia rose. Qualcomm’s fiscal Q1 results are due Feb. 4. The company also announced new PC, automotive, and robotics products at CES in Las Vegas.
7 January 2026
··
Qualcomm (QCOM) stock rises after-hours on Google auto AI pact, CES chip launches

Qualcomm (QCOM) stock rises after-hours on Google auto AI pact, CES chip launches

Qualcomm shares rose 3.5% to $182.45 in after-hours trading Tuesday after CES announcements highlighting new auto and PC initiatives. Qualcomm and Google expanded their automotive partnership to accelerate software-defined vehicles and in-car AI. The company also unveiled Snapdragon X2 Plus chips for Windows laptops and launched new processors for edge AI and robotics.
7 January 2026
·····
Qualcomm stock rises as CES 2026 brings Google auto tie-up, Snapdragon X2 Plus AI PC push

Qualcomm stock rises as CES 2026 brings Google auto tie-up, Snapdragon X2 Plus AI PC push

Qualcomm shares climbed 3.4% to $182.25 after announcing new products and an expanded automotive partnership with Google at CES 2026. The company launched its Snapdragon X2 Plus PC platform and detailed new tools for software-defined vehicles. The stock traded between $176.50 and $184.38 during the session. Investors await further design-win updates and the next quarterly report.
6 January 2026
···
Qualcomm stock jumps at CES 2026 on Snapdragon X2 Plus AI PC launch and robotics push

Qualcomm stock jumps at CES 2026 on Snapdragon X2 Plus AI PC launch and robotics push

Qualcomm shares rose about 3% to $181.64 Tuesday after unveiling new PC and robotics chips at CES 2026. The company said its Snapdragon X2 Plus will power Windows Copilot+ PCs in 2026 and confirmed Toyota will use its Snapdragon Digital Chassis in the next RAV4. Semiconductor ETFs gained 2.7%. Investors await Qualcomm’s fiscal Q1 results on Feb. 4.
6 January 2026
····
Qualcomm stock rises on Google auto AI tie-up, Snapdragon X2 laptop push at CES 2026

Qualcomm stock rises on Google auto AI tie-up, Snapdragon X2 laptop push at CES 2026

Qualcomm shares rose 1.7% to $175.96 Monday after the company and Google expanded their automotive partnership at CES, focusing on long-term software support and “agentic AI.” Qualcomm also unveiled new PC and robotics chips. Investors are watching for further CES design wins and Qualcomm’s Feb. 4 earnings. The Philadelphia Semiconductor Index gained 0.9% in afternoon trading.
5 January 2026
····
Qualcomm stock today: QCOM rises on Toyota RAV4 Snapdragon news as CES, earnings loom

Qualcomm stock today: QCOM rises on Toyota RAV4 Snapdragon news as CES, earnings loom

Qualcomm shares closed up 1.1% at $172.98 Friday, trailing a 4.2% gain in the semiconductor ETF. A U.S. filing showed CFO Akash Palkhiwala plans to sell 3,333 shares worth about $576,542 under a pre-set trading plan. The move followed news that Toyota’s new RAV4 will use Qualcomm’s Snapdragon Digital Chassis. Investors are watching CES events starting Monday for further updates.
3 January 2026
··
Qualcomm stock rises today as chip rally lifts QCOM ahead of CES and Feb. earnings

Qualcomm stock rises today as chip rally lifts QCOM ahead of CES and Feb. earnings

NEW YORK, Jan 2, 2026, 12:41 ET — Regular session Shares of QUALCOMM Incorporated rose 1.3% to $173.26 on Friday, extending an early-year rebound for chip stocks. The stock traded between $172.21 and $174.63, with about 2.1 million shares changing hands by midday. The move matters because Qualcomm sits at the center of smartphone and connected-device supply chains, and its shares often trade with broader sentiment toward semiconductors. Investors are resetting positions at the start of the year after a choppy finish to 2025. It also lands days before CES in Las Vegas, a showcase where chipmakers and device brands
2 January 2026
····
Qualcomm stock closes down to end 2025 as chip shares slide — what QCOM investors watch next

Qualcomm stock closes down to end 2025 as chip shares slide — what QCOM investors watch next

Qualcomm shares fell 1.5% to $171.05 in the final U.S. trading session of 2025, underperforming semiconductor peers as the sector weakened. Trading volume was less than half the 50-day average. The S&P 500 and Nasdaq also closed lower in thin, holiday-shortened trade. Investors now await early January economic data and Qualcomm’s Feb. 4 earnings call.
1 January 2026
···
Qualcomm stock slides in thin year-end trade; QCOM turns to Feb. 4 earnings next

Qualcomm stock slides in thin year-end trade; QCOM turns to Feb. 4 earnings next

Qualcomm closed down 1.5% at $171.05 in the final U.S. trading session of 2025, trailing some semiconductor peers as Wall Street ended the year lower. Trading volume was 4.5 million shares, less than half its 50-day average. The stock finished about 17% below its 52-week high. Markets reopen Jan. 2 after the New Year holiday, with the Federal Reserve’s next policy meeting set for Jan. 27–28.
1 January 2026
···
Qualcomm stock slips in year-end trade as chip shares cool; what QCOM investors watch next

Qualcomm stock slips in year-end trade as chip shares cool; what QCOM investors watch next

NEW YORK, December 31, 2025, 15:13 ET — Regular session QUALCOMM Incorporated shares slipped in afternoon trading on Wednesday, underperforming the broader semiconductor group as U.S. stocks edged lower in holiday-thin year-end trading. The final session of the year often brings portfolio rebalancing and profit-taking — selling to lock in gains — which can amplify moves even when there is little company-specific news. Wall Street’s main indexes were slightly lower on the day, with technology shares dipping as traders looked ahead to 2026, Reuters reported. Reuters At 3:13 p.m. ET, Qualcomm was down $1.79, or about 1.0%, at $171.86 after
31 December 2025
···
1 2 3 4 5 … 7

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop